BIO-RAD LABORATORIES, INC.
BIO BIO.B
7 insider filings · Latest: May 11, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 28, 2026 | May 28 7:04 PM | Alles Institute for Medical Research Corp | Proposed Sale | 700 | $313.28 | $219.3K | — | View → |
| May 11, 2026 | May 13 7:38 PM | Eva Anette EngelhardtEVP, President, CDG | Sale | 550 | $246.54 | $135.6K | 346(D) | View → |
| May 11, 2026 | May 11 9:03 PM | EVA ENGELHARDT | Proposed Sale | 550 | $246.54 | $135.6K | — | View → |
| Dec 2, 2025 | Dec 2 11:27 PM | MICHAEL W CROWLEY | Proposed Sale | 776 | $319.56 | $248.0K | — | View → |
| Nov 18, 2025 | Nov 18 6:03 PM | Alles Institute for Medical Research Corp | Proposed Sale | 760 | $301.04 | $228.8K | — | View → |
| Nov 6, 2025 | Nov 6 9:24 PM | JAMES BARRY | Proposed Sale | 701 | $306.18 | $214.6K | — | View → |
| Aug 5, 2025 | Aug 5 8:47 PM | MICHAEL W CROWLEY | Proposed Sale | 1,488 | $275.92 | $410.6K | — | View → |
| Mar 13, 2025 | Mar 13 9:17 PM | Crowley Michael | Proposed Sale | 3,000 | $260.00 | $780.0K | — | View → |
| Mar 11, 2025 | Mar 11 4:36 PM | Alles Institute for Medical Research Corp | Proposed Sale | 410 | $247.66 | $101.5K | — | View → |
| Nov 6, 2024 | Nov 6 11:26 PM | Last Andrew J. | Proposed Sale | 3,000 | $373.64 | $1.1M | — | View → |
| Sep 12, 2024 | Sep 12 10:22 PM | Last Andrew J. | Proposed Sale | 1,600 | $321.57 | $514.5K | — | View → |
| Sep 6, 2024 | Sep 6 8:16 PM | Last Andrew J. | Proposed Sale | 3,000 | $329.94 | $989.8K | — | View → |
| Sep 4, 2024 | Sep 4 10:24 PM | BARRY JAMES | Proposed Sale | 623 | $330.49 | $205.9K | — | View → |
| Aug 27, 2024 | Aug 27 4:45 PM | Alles Institute for Medical Research Corp | Proposed Sale | 990 | $311.34 | $308.2K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 24, 2026 | Apr 28 4:21 PM | Roop Kalyan LakkarajuEVP, Chief Financial Officer | Option Exercise | 1,078 | — | 2,156(D) | View → |
| Apr 24, 2026 | Apr 28 4:20 PM | Courtney C EnloeEVP, General Counsel & Sec | Option Exercise | 186 | — | 372(D) | View → |
| Apr 21, 2026 | Apr 23 7:26 PM | Greg K HinckleyDirector | Grant/Award | 369 | — | 369(D) | View → |
| Apr 21, 2026 | Apr 23 7:26 PM | Greg K HinckleyDirector | Option Exercise | 407 | — | 0(D) | View → |
| Apr 21, 2026 | Apr 23 7:25 PM | Melinda Litherland PeiDirector | Grant/Award | 369 | — | 369(D) | View → |
| Apr 21, 2026 | Apr 23 7:25 PM | Melinda Litherland PeiDirector | Option Exercise | 407 | — | 0(D) | View → |
| Apr 21, 2026 | Apr 23 7:24 PM | Jeffrey L EdwardsDirector | Grant/Award | 369 | — | 369(D) | View → |
| Apr 21, 2026 | Apr 23 7:24 PM | Jeffrey L EdwardsDirector | Option Exercise | 407 | — | 0(D) | View → |
| Apr 21, 2026 | Apr 23 7:23 PM | Arnold A PinkstonDirector | Option Exercise | 407 | — | 0(D) | View → |
| Apr 21, 2026 | Apr 23 7:23 PM | Arnold A PinkstonDirector | Grant/Award | 369 | — | 369(D) | View → |